Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-810-4 | CAS number: 7747-35-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
The acute oral toxicity of CS-1246 is low with LD50 levels in male and female rats at 5249 mg/kg (4503-6673 mg/kg), and 3674 mg/kg (3216-4197 mg/kg) respectively.
The acute dermal toxicity in the rat is therefore greater than 2,000 mg/kg. In an acute dermal toxicity study in the rabbit with abraded skin the dermal LD50 was 1948 mg/kg (1596-18495 mg/kg). The acute dermal study in rat is considered to be the key study for this enpoint as it meets current protocol guidelines and is conducted to GLP.
The acute inhalation LC50 was calculated to be 3.1 mg/L (95% CI, 2.7-3.5 mg/L)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 3 674 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 3.1 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
Additional information
To assess the acute oral toxicity of CS-1246 rats (10/sex/group) were treated by oral gavage at doses 0, 2,100, 3000, 4,200 or 6,000 mg/kg (Parekh, C. 1980) Animals were observed frequently on the day of dosing, and daily thereafter for 14 days. Any unusual signs of toxicity or death were noted. Animals were subjected to a gross pathological examination as soon as possible after spontaneous death, or at the scheduled necropsy on day 14. The acute oral toxicity of CS-1246 is low with LD50levels in male and female rats at 5249 mg/kg (4503-6673 mg/kg), and 3674 mg/kg (3216-4197 mg/kg) respectively.
The acute dermal toxicity of CS-1246 was tested in 5 male and 5 female Wistar rats at a dose of 2000 mg/kg body weight (Ravi, G. S. (2009)). All rats gained body weight through the observation period. No local skin reactions were observed. No pre-terminal deaths occurred and no abnormalities were detected at necropsy. The acute dermal toxicity in the rat is therefore greater than 2,000 mg/kg. In an acute dermal toxicity study in the rabbit with abraded skin the dermal LD50was 1948 mg/kg (1596-18495 mg/kg).
For the acute inhalation study rats, (5 male and 5 female per treatment group), were exposed (whole-body) to aerosols of CS-1246, (particle size distributions ranged from 3.9-4.7 microns MMAD), to give exposure concentrations of 0, 1.6, 2.4, 2.6, 3.3 or 4.5 mg/litre (Terrill, J.B. and Hogan, G.K., 1982). All test material-dependent deaths occurred on the day of or the day after exposure. In the absence indications of systemic injury, the rapid death suggests severe irritation/injury to the respiratory tract. Histopathological examination of the lungs of the lungs of all rats failed to show treatment-related pulmonary injury. This suggests irritation/injury to the upper respiratory tract, however, no examination of the nasal airways was conducted. The acute inhalation LC50 was calculated to be 3.1 mg/L (95% CI, 2.7-3.5 mg/L).
References:
Parekh, C. (1980) Acute Toxicity Profile of P-1601 (Oxazolidine E).
International Minerals and Chemicals Corp. The Dow Chemical Company Report No: DR-0365-7725-001. Not GLP, Unpublished
Ravi, G. S. (2009) BIOBAN CS-1246: Acute Dermal Toxicity Study in Rats.
Advinus Therateutics Private
Limited. Bangolore, Study No. G6693.
The Dow Chemical Company Report No: DR-0365-7827-016. GLP, Unpublished
Terrill, J.B. and Hogan, G.K. (1982) An Acute Inhalation Toxicity Study of ZOLDINE ZE (P-1601) in the Rat. BIODYNAMICS Inc. The Dow Chemical Company Report No: DR-0365-7725-002 Not GLP, Unpublished
Justification for classification or non-classification
Based on the oral and dermal LD50 values above 2000 mg/kg/day, classification for acute toxicity via these routes are not warranted according both EU Directive 67/548/EEC and CLP Regulation (EC) No. 1272/2008.
Based on the inhalation LC50 value, classification for acute toxicity via the inhalation route of exposure is Xn R20 according to EU Directive 67/548/EEC and Cat 4 acute tox H332 (Harmful if inhaled) according to CLP Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
